Breast cancer: An overview of published Indian data

B Rangarajan, T Shet, T Wadasadawala… - South Asian journal …, 2016 - thieme-connect.com
The Incidence of breast cancer has been steadily increasing in the last two decades, more
so in urban areas of the sub-continent. Cancer ceters across the country have large …

[HTML][HTML] ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary …

C Coyle, FH Cafferty, S Rowley, M MacKenzie… - Contemporary clinical …, 2016 - Elsevier
Background There is a considerable body of pre-clinical, epidemiological and randomised
data to support the hypothesis that aspirin has the potential to be an effective adjuvant …

Pushing estrogen receptor around in breast cancer

E Lim, G Tarulli, N Portman, TE Hickey… - Endocrine-related …, 2016 - erc.bioscientifica.com
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant endocrine tumor
syndrome, caused by inactivating mutations of the MEN1 tumor suppressor gene at 11q13 …

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast …

LX Yan, YH Liu, JW Xiang, QN Wu… - International …, 2016 - spandidos-publications.com
We have previously shown that dysregulation of miR-21 functioned as an oncomiR in breast
cancer. The aim of the present study was to elucidate the mechanisms by which miR-21 …

[PDF][PDF] Breast cancer: Indian experience, data, and evidence

S Gupta - South Asian journal of cancer, 2016 - thieme-connect.com
Breast cancer is now the most common cancer in Indian women,[1] having recently
overtaken cervical cancer in this respect. It is therefore in fitness of things that Rangarajan et …

Renewed interest in the progesterone receptor in breast cancer

E Lim, C Palmieri, WD Tilley - British journal of cancer, 2016 - nature.com
The progesterone receptor (PgR), a member of the nuclear receptor family, is a well-known
oestrogen receptor (ER)-regulated gene that is expressed in over two-thirds of ER-positive …

Adjuvant surgical oophorectomy plus tamoxifen in premenopausal women with operable hormone receptor–positive breast cancer: A global treatment option

RR Love - Clinical Breast Cancer, 2016 - Elsevier
One third of annual new cases of breast cancer globally are now hormone receptor–positive
tumors in premenopausal women from low-and middle-income countries. For this subgroup …

Barriers in conducting clinical trials in oncology in the developing world: a cross-sectional survey of oncologists

M Dandekar, R Trivedi, N Irawati… - Indian journal of …, 2016 - journals.lww.com
BACKGROUND: Several obstacles impede oncologists from performing clinical trials in the
developing world. This study aimed to identify these barriers in order of importance and …

[HTML][HTML] Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer

RR Love, SM Hossain, MM Hussain… - European Journal of …, 2016 - Elsevier
Purpose In premenopausal women with metastatic hormone receptor-positive breast cancer,
hormonal therapy is the first-line therapy. Gonadotropin-releasing hormone analogue+ …

Misdiagnosis of Cancer as Tuberculosis in Low-to Middle-Income Countries: A Tip of the Iceberg!

A Hannan - Journal of Global Oncology, 2016 - ncbi.nlm.nih.gov
In their recent article inJournal of Global Oncology, Masamba et al 1 concluded that
misdiagnosis of cancer as tuberculosis is a major concern in low-to middle-income countries …